Sebastian Schneeweiss
Vice Chief, Professor of Medicine and Epidemiology at Harvard T.H. Chan School of Public Health
Schools
- Harvard T.H. Chan School of Public Health
Links
Biography
Harvard T.H. Chan School of Public Health
Sebastian Schneeweiss is Professor of Medicine and Epidemiology at Harvard Medical School and Vice Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine, Brigham and Women’s Hospital, a world-leading research and training center. His research is funded by multiple NIH, PCORI, and FDA grants and focuses on the comparative effectiveness and safety of biopharmaceuticals. He has developed analytic methods to improve the scientific validity of epidemiologic analyses using complex longitudinal healthcare databases particularly for newly marketed medical products. Applying such methods transparently and in rapid cycles for sequential medication effectiveness monitoring is the overarching theme of his research. His work is published in >350 articles. He is Aetion Inc.’s Science Lead were he develops a worldwide network of rapid-cycle analytics platforms that produces evidence fit for decision making in healthcare. Dr. Schneeweiss is Director of the Harvard-Brigham Drug Safety Research Center funded by FDA/CDER and Co-Chair of the Methods Core of the FDA Sentinel program. He is voting consultant to the FDA Drug Safety and Risk Management Advisory Committee and was inaugural member of the Methods Committee of the Patient Centered Outcomes Research Institute. He was President of the International Society for Pharmacoepidemiology, inaugural member of the PCORI Methods Committee and is Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology. At Harvard he teaches courses on Database Analytics for Pharmacoepidemiology and on Effectiveness Research in Longitudinal Healthcare Databases among others. He received his medical training at the Ludwig-Maximilians University of Munich and his doctoral degree in pharmacoepidemiology from Harvard.
Videos
Introduction to issue
Dr Sebastian Schneeweiss Discusses How Rapid-Cycle Analytics Can Evaluate Drug Safety, Efficacy
Read about executive education
Other experts
Naomi Warren
PhD, University of Texas at Austin; MA, CSU-Los Angeles; BS, Portland State University Naomi Warren specializes in communication issues related to diversity, equity, and inclusion, with a particular emphasis on race, gender, social class, media representations, politics, and policy. Her teaching...
Laure Cabantous
Laure is Professor of Strategy and Organization at Cass Business School. She has a specific interest for the performative power of theories - that is their ability to shape the world and business practices. Laure also studies decision-making practices, both at the organizational and the individua...
Cathelijn van Leeuwen
Vanuit mijn achtergrond in de psychologie ligt mijn affiniteit en expertise bij het gedrag van mensen in hun werkcontext, met name in relatie tot hun communicatie. Sinds 2008 werk ik als zelfstandig coach. Ik begeleid managers en professionals bij het verder ontwikkelen van hun persoonlijke effe...
Popular Courses
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
Leading People and Teams
ESMT
Berlin, Germany
May 28
Looking for an expert?
Contact us and we'll find the best option for you.